Clinical trial
Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing…
NCT01605006 · Synapse Biomedical, Industry · Completed
Key facts
| NCT number | NCT01605006 |
|---|---|
| Title | Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis |
| Official title | HDE Post-Approval Study (PAS) of NeuRx DPS for ALS |
| Lead sponsor | Synapse Biomedical, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis (ALS) |
| Intervention type | Device |
| Interventions | NeuRx Diaphragm Pacing System (DPS) |
| Enrollment | 97 |
| Start date | Jul 1, 2012 |
| Primary completion | Feb 1, 2017 |
| Completion | Feb 1, 2017 |
| First posted | May 24, 2012 |
| Last update posted | Mar 27, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: